Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS
· Delayed Price · Currency is USD
0.674
-0.036 (-5.10%)
At close: Apr 28, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 20 employees as of December 31, 2025. The number of employees decreased by 7 or -25.93% compared to the previous year.
Employees
20
Change (1Y)
-7
Growth (1Y)
-25.93%
Revenue / Employee
n/a
Profits / Employee
-$515,350
Market Cap
7.43M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NKGen Biotech | 26 |
| Galera Therapeutics | 3 |
| Synlogic | 1 |
| ZIVO Bioscience | 7 |
| Orgenesis | 77 |
Brainstorm Cell Therapeutics News
- 4 weeks ago - BrainStorm Cell Therapeutics Announces Full Year 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - PRNewsWire
- 2 months ago - Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market - PRNewsWire
- 5 months ago - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 months ago - Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 9 months ago - Brainstorm Cell Therapeutics Earnings Call Transcript: Q2 2025 - Transcripts
- 9 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 9 months ago - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - PRNewsWire